Summary and prospective statement concerning the genitourinary workshop.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000628:therapy*; D011832:Radiation Injuries / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage; D013311:Streptozocin / Q000009:adverse effects; D013997:Time Factors; D014566:Urogenital System / Q000187:drug effects* / Q000528:radiation effects*
D000970:Antineoplastic Agents; D013311:Streptozocin; D003520:Cyclophosphamide; D002945:Cisplatin; D008727:Methotrexate